Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Seierstad

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Bioorganic & Medicinal Chemistry Letters|February 12, 2014
1-Aryl-2-((6-aryl)pyrimidin-4-yl)amino)ethanols as competitive inhibitors of fatty acid amide hydrolaseJohn M Keith, Natalie Hawryluk, Richard L Apodaca, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2014
Heteroarylureas with spirocyclic diamine cores as inhibitors of fatty acid amide hydrolaseJohn M Keith, William M Jones, Joan M Pierce, et al.
ACS Medicinal Chemistry Letters|August 22, 2018
Lead Optimization of 5-Aryl Benzimidazolone- and Oxindole-Based AMPA Receptor Modulators Selective for TARP γ-8Suchitra Ravula, Brad M Savall, Nyantsz Wu, et al.
Bioorganic & Medicinal Chemistry Letters|May 19, 2016
The SAR of brain penetration for a series of heteroaryl urea FAAH inhibitorsJohn M Keith, Mark S Tichenor, Richard L Apodaca, et al.
Bioorganic & Medicinal Chemistry Letters|November 13, 2012
Heteroaryl urea inhibitors of fatty acid amide hydrolase: structure-mutagenicity relationships for arylamine metabolitesMark S Tichenor, John M Keith, William M Jones, et al.
ACS Medicinal Chemistry Letters|May 31, 2021
Discovery of a Potent and Selective Covalent Inhibitor of Bruton's Tyrosine Kinase with Oral Anti-Inflammatory ActivityMark S Tichenor, John J M Wiener, Navin L Rao, et al.
Journal of Medicinal Chemistry|March 6, 2020
Discovery of a Gut-Restricted JAK Inhibitor for the Treatment of Inflammatory Bowel DiseaseKristi A Leonard, Lisa A Madge, Paul J Krawczuk, et al.
Journal of Medicinal Chemistry|October 31, 2022
Discovery of JNJ-64264681: A Potent and Selective Covalent Inhibitor of Bruton's Tyrosine KinaseMark S Tichenor, John J M Wiener, Navin L Rao, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 26, 2023
Identification of highly selective SIK1/2 inhibitors that modulate innate immune activation and suppress intestinal inflammationHolger Babbe, Thomas B Sundberg, Mark Tichenor, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Bioorganic & Medicinal Chemistry Letters|February 12, 2014
1-Aryl-2-((6-aryl)pyrimidin-4-yl)amino)ethanols as competitive inhibitors of fatty acid amide hydrolaseJohn M Keith, Natalie Hawryluk, Richard L Apodaca, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2014
Heteroarylureas with spirocyclic diamine cores as inhibitors of fatty acid amide hydrolaseJohn M Keith, William M Jones, Joan M Pierce, et al.
ACS Medicinal Chemistry Letters|August 22, 2018
Lead Optimization of 5-Aryl Benzimidazolone- and Oxindole-Based AMPA Receptor Modulators Selective for TARP γ-8Suchitra Ravula, Brad M Savall, Nyantsz Wu, et al.
Bioorganic & Medicinal Chemistry Letters|May 19, 2016
The SAR of brain penetration for a series of heteroaryl urea FAAH inhibitorsJohn M Keith, Mark S Tichenor, Richard L Apodaca, et al.
Bioorganic & Medicinal Chemistry Letters|November 13, 2012
Heteroaryl urea inhibitors of fatty acid amide hydrolase: structure-mutagenicity relationships for arylamine metabolitesMark S Tichenor, John M Keith, William M Jones, et al.
ACS Medicinal Chemistry Letters|May 31, 2021
Discovery of a Potent and Selective Covalent Inhibitor of Bruton's Tyrosine Kinase with Oral Anti-Inflammatory ActivityMark S Tichenor, John J M Wiener, Navin L Rao, et al.
Journal of Medicinal Chemistry|March 6, 2020
Discovery of a Gut-Restricted JAK Inhibitor for the Treatment of Inflammatory Bowel DiseaseKristi A Leonard, Lisa A Madge, Paul J Krawczuk, et al.
Journal of Medicinal Chemistry|October 31, 2022
Discovery of JNJ-64264681: A Potent and Selective Covalent Inhibitor of Bruton's Tyrosine KinaseMark S Tichenor, John J M Wiener, Navin L Rao, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 26, 2023
Identification of highly selective SIK1/2 inhibitors that modulate innate immune activation and suppress intestinal inflammationHolger Babbe, Thomas B Sundberg, Mark Tichenor, et al.
Pageof 3